Atsushi Sakuraba, MD
Gastroenterology · Chicago, ILNPI 1366756140
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $75,291 of the $76,230 with a category attached, or 98.8%. Fujifilm Healthcare Americas Corporation accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $75,291 and has fallen 98.8% since, to $899 in 2023. Among gastroenterology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 5 payments — averaging $15,246 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fujifilm Healthcare Americas Corporation$76K
- Takeda Pharmaceuticals U.S.A., Inc.$40
- AbbVie$21
Across 6 payments — averaging $17,782 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Fujifilm Healthcare Americas Corporation$34K
- Celltrion, Inc.$33K
- Takeda Pharmaceuticals U.S.A., Inc.$23K
- Pfizer$16K
- Eli Lilly$2K
What the payments were for
- Consulting fees$8781%
- Food & beverage$610%
- Gifts$75,29199%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fujifilm Healthcare Americas Corporation | 3 | $76,169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| AbbVie | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ESD - Core Endoscopy$75,291
- FUJIFILM$878
How this compares
$76,230 in reported general payments places this provider in the 90th percentile of 787 gastroenterology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 26 | $678,854 |
| Skyrizi On-BodyRisankizumab-Rzaa | 13 | $261,246 |
| Humira(Cf) PenAdalimumab | 12 | $121,882 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 27 | $1,735 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 47 | $778 |
| Colestipol Hcl | 13 | $729 |
| Sulfasalazine | 12 | $220 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Chicago
- David RubinChicago$1.5M
- Stephen HanauerChicago$1.4M
- Steven FlammChicago$1.3M
- Darren BrennerChicago$1.1M
- Russell CohenChicago$690K
- Parambir DulaiChicago$668K
- Christopher ChapmanChicago$645K
- Saurabh KapurChicago$532K
- Ikuo HiranoChicago$457K
- Adam SteinChicago$438K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.